NCT00989287View on ClinicalTrials.gov

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

October 7, 2009

Primary Completion Date

October 9, 2009

Study Completion Date

October 26, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

GSK2340272A

Two intramuscular injections in the deltoid region of the non-dominant arm.

BIOLOGICAL

GSK2340269A

Two intramuscular injections in the deltoid region of the non-dominant arm.

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00989287 - Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults | Biotech Hunter | Biotech Hunter